BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21275130)

  • 1. Immunoglobulin light chain amyloidosis associated with multiple myeloma in a young patient: a case report.
    Morais OO; Costa LO; Shinzato DH; Hans-Filho G
    West Indian Med J; 2010 Mar; 59(2):219-21. PubMed ID: 21275130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis.
    Elad S; Czerninski R; Fischman S; Keshet N; Drucker S; Davidovich T; Goldschmidt N
    Amyloid; 2010 Mar; 17(1):27-31. PubMed ID: 20146645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
    Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
    Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bilateral pleurisy revealing a myelome with free light chains complicated with an osseous amylose].
    El Boukhrissi F; Balouch L; Hachimi MA; Hommadi A; Idrissi MM; Bamou Y
    Ann Biol Clin (Paris); 2011; 69(5):593-6. PubMed ID: 22008141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient with multiple myeloma, amyloidosis and light-chain deposition disease in kidneys with a long survival.
    Christou L; Hatzimichael EC; Sotsiou-Candila F; Siamopoulos K; Bourantas KL
    Acta Haematol; 1999; 101(4):202-5. PubMed ID: 10436302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of amyloidosis complicated by IgU/lambda/-myeloma multiplex].
    Husz S; Török L; Kovács L; Szabó E; Simon N
    Z Hautkr; 1979 Jul; 54(13):585-9. PubMed ID: 113946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease.
    Lorenz EC; Sethi S; Poshusta TL; Ramirez-Alvarado M; Kumar S; Lager DJ; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2010 Apr; 25(4):1340-3. PubMed ID: 20061318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of light chain (AL) amyloidosis associated with IgD multiple myeloma (MM): clinical features, laboratory findings and outcome.
    Rizzi R; Miccolis R; Rinaldi E; Bonerba B; Rossini M; Manno C; Curci P; Specchia G; Liso V
    Amyloid; 2011 Jun; 18 Suppl 1():117-8. PubMed ID: 21838455
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
    Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
    Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic amyloidosis and multiple myeloma. Report of a case with the association of light chain myeloma and gastric plasmacytosis (author's transl)].
    Libeskind M; Malbran J; Lugagne F; Agard D; Gatineau-Saillant C; Guyet-Rousset P
    Gastroenterol Clin Biol; 1977 Mar; 1(3):267-74. PubMed ID: 408215
    [No Abstract]   [Full Text] [Related]  

  • 12. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
    Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
    Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual heart failure: cardiac amyloidosis due to light-chain myeloma.
    Martinelli N; Carleo P; Girelli D; Olivieri O
    Circulation; 2011 May; 123(18):e583-4. PubMed ID: 21555719
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary (AL) amyloidosis in plasma cell disorders.
    Müller AM; Geibel A; Neumann HP; Kühnemund A; Schmitt-Gräff A; Böhm J; Engelhardt M
    Oncologist; 2006; 11(7):824-30. PubMed ID: 16880241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
    Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
    Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetany and osteolysis in light chain myeloma with amyloidosis.
    Bhakri HL; Cundy TF; Pettingale KW
    Postgrad Med J; 1983 Aug; 59(694):527-9. PubMed ID: 6413962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by Falk regarding article, "An unusual heart failure: cardiac amyloidosis due to light chain myeloma".
    Falk RH
    Circulation; 2011 Nov; 124(20):e534; author reply e535. PubMed ID: 22083153
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma-associated light chain amyloidosis presenting as verrucous lingual masses.
    Lee KH; Lee JS; Cho YK; Kim SY; Yoo JY; Park CJ
    Acta Derm Venereol; 2005; 85(5):447-8. PubMed ID: 16159741
    [No Abstract]   [Full Text] [Related]  

  • 19. AL amyloidosis or multiple myeloma? An important distinction.
    Falk RH
    Br J Haematol; 2014 Mar; 164(5):748-9. PubMed ID: 24261595
    [No Abstract]   [Full Text] [Related]  

  • 20. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.